KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Equity (2016 - 2025)

Historic Return on Equity for West Pharmaceutical Services (WST) over the last 16 years, with Q3 2025 value amounting to 0.16%.

  • West Pharmaceutical Services' Return on Equity fell 200.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.17% for FY2024, which is 400.0% down from last year.
  • As of Q3 2025, West Pharmaceutical Services' Return on Equity stood at 0.16%, which was down 200.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Return on Equity registered a high of 0.28% during Q1 2022, and its lowest value of 0.16% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.22%, with a median of 0.2% in 2024.
  • Per our database at Business Quant, West Pharmaceutical Services' Return on Equity surged by 1000bps in 2021 and then tumbled by -1000bps in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Return on Equity (Quarter) stood at 0.28% in 2021, then fell by -22bps to 0.22% in 2022, then dropped by -9bps to 0.2% in 2023, then decreased by -12bps to 0.18% in 2024, then dropped by -9bps to 0.16% in 2025.
  • Its Return on Equity stands at 0.16% for Q3 2025, versus 0.17% for Q2 2025 and 0.17% for Q1 2025.